This HTML5 document contains 181 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n9http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n11https://w3id.org/oc/corpus/br/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n13http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q28269931
rdf:type
wikibase:Item
schema:description
2012年論文 wissenschaftlicher Artikel vitskapeleg artikkel tieteellinen artikkeli artículo científico publicado en 2012 2012 թուականի Յունիսին հրատարակուած գիտական յօդուած bilimsel makale ২০১২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ naučni članak 2012年论文 научна статия 2012年論文 سائنسی مضمون artykuł naukowy artikulong pang-agham 2012 nî lūn-bûn artículu científicu espublizáu en 2012 2012년 논문 wetenschappelijk artikel (gepubliceerd op 2012/06/30) scienca artikolo наукова стаття, опублікована в червні 2012 мақолаи илмӣ artigo científico (publicado na 2012) 2012年论文 2012年論文 articol științific vetenskaplig artikel vedecký článok (publikovaný 2012/06/30) article scientific სამეცნიერო სტატია 2012年论文 scientific article article scientifique (publié 2012) 2012年論文 2012 թվականի հունիսին հրատարակված գիտական հոդված artikull shkencor مقالهٔ علمی vědecký článek publikovaný v roce 2012 บทความทางวิทยาศาสตร์ 2012年论文 bài báo khoa học научная статья tudományos cikk 2012年論文 ശാസ്ത്രപ്രബന്ധം​ 2012年论文 article científic teaduslik artikkel articolo scientifico mokslinis straipsnis 2012年の論文 мақолаи илмӣ vitenskapelig artikkel научни чланак artigo científico научни чланак מאמר מדעי videnskabelig artikel (udgivet 2012) artigo científico (publicado na 2012) مقالة علمية (نشرت في 30-6-2012) 2012年论文 επιστημονικό άρθρο
p:P577
wds:Q28269931-987E2E74-A0F7-4130-BFDC-6AB127BF68FA
wdt:P577
2012-06-30T00:00:00Z
p:P407
wds:Q28269931-629411AA-04B1-4B57-BD17-DAE6EBB51BD5
wdt:P407
wd:Q1860
p:P2860
wds:Q28269931-2225A26A-8B4B-4271-9C98-1712C0DA8605 wds:Q28269931-03B9D274-773C-41F5-AB3C-912115BB1EFB wds:Q28269931-066D545F-2779-41DA-86DD-84CC33A5B1C8 wds:Q28269931-0BE4AB96-E6DE-483A-9178-8A14A846278A wds:Q28269931-32C34120-37E0-46D5-9BDE-5DBAE6FD87D4 wds:Q28269931-52CBB2A6-2785-4C65-A42A-DCC0D3FD3342 wds:Q28269931-55FFDD15-0B57-438C-A68F-43FFE88C212B wds:Q28269931-8112DE90-0CAB-4462-825C-180AEF6A1BCD wds:Q28269931-819C9E7B-E580-404D-989E-CE579D596DAE wds:Q28269931-67298BDB-6ED7-4F65-8A6A-44B2A0519B54 wds:Q28269931-68BA2BDC-2A16-4B4F-AB44-56176CFC6A97 wds:Q28269931-7748BBB9-CE3E-4056-B7FE-8AFAB923BF63 wds:Q28269931-780903DB-2C6F-46D3-8601-D043BDD396EB wds:Q28269931-B10C3DBC-85F3-4078-837F-114F220A7BE6 wds:Q28269931-8A2621D1-B2D0-47CE-8C7A-AD0219A4FFD1 wds:Q28269931-9810D309-2D60-4039-A15A-E7631581EAFE wds:Q28269931-9887725C-3460-449B-ABD5-38D248B53E36 wds:Q28269931-B95D433F-36C3-41A3-AC47-317429964A1C wds:Q28269931-BD902965-D392-4924-BF15-4A97FF9FE64D wds:Q28269931-C0FE71D1-30F5-4F68-9631-E4A7B592EEF1 wds:Q28269931-FAE54730-2B95-4093-999D-9EB41B880EB8 wds:Q28269931-16F5C2EF-EC38-423B-A387-84CC150B37C2
wdt:P2860
wd:Q53750673 wd:Q43651001 wd:Q42635936 wd:Q43161852 wd:Q45910955 wd:Q37304808 wd:Q33565604 wd:Q46900196 wd:Q80176025 wd:Q36518993 wd:Q36610691 wd:Q37773748 wd:Q84656730 wd:Q57180178 wd:Q44513458 wd:Q51547763 wd:Q29615603 wd:Q48565770 wd:Q44849439 wd:Q34181784 wd:Q24656978 wd:Q43300648
p:P2093
wds:Q28269931-2B3F5F80-4A33-4631-93DE-A8D29AF2112E wds:Q28269931-31ADA550-4E1D-4FFB-9A16-19F8E3D62E63 wds:Q28269931-2AC9AE86-F0BD-4945-87E9-1DB2389A70A3 wds:Q28269931-5E1CD95C-50A5-4E40-818F-45FABBEE4173 wds:Q28269931-539FDD7F-A98D-4286-9DD0-87AACD6DD1EE wds:Q28269931-621AABED-4D99-4D1F-B14D-B32B0EE3B6FB wds:Q28269931-EE89E0CB-5627-4BE6-9390-F4C13343D820 wds:Q28269931-EEF4930C-4757-4338-A8B2-F884FEC24764 wds:Q28269931-F6579FA7-0161-4CB6-9639-E0727D6223F6 wds:Q28269931-7A9840C4-4228-498A-BFE0-5BF282D6925A wds:Q28269931-A755342E-0899-4FF5-BF35-47F5D3C76A21 wds:Q28269931-9E23A715-D18B-4325-9088-6DC2185B1115 wds:Q28269931-A113F698-CAC4-4224-A759-1A3DF353A7CA
p:P3181
wds:Q28269931-22AC40C6-750A-49D3-AF14-4BB4615CFA6F
wdtn:P3181
n11:1501170
wdt:P2093
Lijie Zhong Kitty Yale Kirsten White Calvin Cohen David Wohl Edwin DeJesus Hui C Liu Javier Szwarcberg Joel E Gallant Erin Quirk Brian P Kearney Andrew Zolopa Andrew K Cheng
wdt:P3181
1501170
rdfs:label
Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks
skos:prefLabel
Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks
schema:name
Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks
p:P50
wds:Q28269931-C58802CC-C1CF-4396-BBA0-D75137A1D6BB wds:Q28269931-3381F077-414E-461F-AFBA-2EDB1C5A7B44
wdt:P50
wd:Q42623352 wd:Q91303052
p:P1476
wds:Q28269931-7AE41222-481C-47F9-84A6-05C59700350F
wdt:P1476
Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks
p:P304
wds:Q28269931-5E35C5CE-D0BC-4286-9F04-6169B80D37C9
wdt:P304
2439-48
p:P31
wds:Q28269931-F40CA057-A117-4C01-9846-33BBCC20592A
wdt:P31
wd:Q13442814
p:P921
wds:Q28269931-031C5C60-1939-45E9-B922-A24730C00404 wds:Q28269931-17888580-521E-4B80-8578-1FECF12C03AB wds:Q28269931-60FEF23B-D667-4504-8A2B-6D7916D9153B wds:Q28269931-33F23DB4-8355-4A1B-9889-E9E31CD5787F wds:Q28269931-42099F22-DFF6-4D61-8F3C-B6BB8A7EA4EE
wdt:P921
wd:Q42824827 wd:Q422604 wd:Q422645 wd:Q155954 wd:Q5138908
p:P698
wds:Q28269931-CD448660-3488-4117-B6A7-E9DB73889015
wdtn:P698
n13:22748591
wdt:P698
22748591
p:P1433
wds:Q28269931-1BAD7A6E-70E8-497D-9001-C69C6E0345A7
wdt:P1433
wd:Q939416
p:P433
wds:Q28269931-F4C4ECBA-7CCA-43B7-BDD7-0BAE49766060
p:P478
wds:Q28269931-B3362633-1C64-4E9F-A06B-62FF8F771B7E
wdt:P433
9835
wdt:P478
379
p:P356
wds:Q28269931-F7C6D9A0-D386-45B3-9348-51276165FC45
wdtn:P356
n9:S0140-6736(12)60917-9
wdt:P356
10.1016/S0140-6736(12)60917-9